September 26, 2016 2:42 AM ET

Biotechnology

Company Overview of Anadys Pharmaceuticals Inc.

Executive Profile

Devron R. Averett Ph.D.

Chief Scientific Counsel and Member of Clinical & Scientific Advisory Board, Anadys Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
66--

Background

Dr. Devron R. Averett, Ph.D. has been Chief Scientific Advisor of YM BioSciences Australia Pty Ltd since July 2008. Dr. Averett has been Chief Scientific Counsel of Anadys Pharmaceuticals Inc. since August 17, 2007. Dr. Averett served as Chief Scientific Officer of Anadys Pharmaceuticals Inc. since October 6, 2004 until August 17, 2007 and served as its Head of Research since October 6, 2004. Dr. Averett served as Senior Vice President of Drug Development of Anadys Pharmaceuticals ...

Corporate Headquarters

5871 Oberlin Drive
San Diego, California 92121

United States

Phone: 858-530-3600
Fax: 858-527-1540

Board Members Memberships

There is no Board Members Memberships data available.

Education

MS
University of Georgia
BS
University of Georgia
PhD
University of North Carolina

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Anadys Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.